Across major studies of semaglutide and tirzepatide, roughly 10% to 15% of patients failed to lose at least 5% of their starting body weight
The best choice depends on your goals, lifestyle, and any identified nutrient gaps discussed during your visit
Tirzepatide, commonly known under the brand name Mounjaro, is a dual-action medication that mimics both GLP-1 and GIP hormones to regulate blood sugar and appetite
How GLP-1 changes your relationship with food and hunger signals GLP-1 medications fundamentally alter your GLP-1 food relationship changes by restoring your connection to true physiological hunger and satiety signals
Oily and acne-prone skin Oily skin types benefit from lightweight, water-based copper peptide formulations that absorb quickly without adding shine
What GLP-1 Medications Cannot Guarantee A specific amount of weight loss for every individual Results identical to clinical trial averages Long-term weight maintenance without continued effort and follow-up Clinical trials typically combined medication with reduced-calorie diets, increased physical activity, and nutritional counseling